Early Efficacy of Tamsulosin Versus Terazosin in the Treatment of Men With Benign Prostatic Hyperplasia: A Randomized, Open-Label Trial
نویسندگان
چکیده
Background: We evaluated the efficacy and tolerability of tamsulosin versus terazosin in patients with signs and symptoms of benign prostatic hyperplasia (BPH). Methods: Patients (N = 1,993) were randomized to tamsulosin (0.4 mg/day) or terazosin (5 mg/day, following titration). The primary efficacy endpoint was total American Urological Association Symptom Index (AUA-SI) score after 4 days of treatment. Secondary endpoints were score changes on measures of BPH symptoms and other clinical assessments made at 6 time points through study-end
منابع مشابه
Ejaculatory Dysfunction Caused by Alpha Blockers for the Treatment of Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia: A Systematic Review and Network Meta-analysis
To provide a systematic review and network meta-analysis of randomized clinical trials focus on ejaculatory dysfunction (ED) rate of alpha blockers (ABs) for treatment of lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH), a systematic literature search was performed to identify all available published randomized controlled trial (RCTs) as regards ABs for the tre...
متن کاملComparison of the Effect of Pumpkin Seed Oil and Tamsulosin on Benign Prostatic Hyperplasia
Background and Objective: Despite a long history of drug treatment for BPH, the side effects and costs associated with current drugs have led to efforts for finding drugs with the same effectiveness and fewer side effects. Also, in recent years, the tendency to use herbal drugs in BPH treatment has increased significantly. Alphablockers are currently the most commonly used chemical drugs in the...
متن کاملTamsulosin versus terazosin for benign prostatic hyperplasia: a systematic review.
The effectiveness and safety of tamsulosin and terazosin for patients with benign prostatic hyperplasia (BPH) was evaluated by literature review. PubMed, Embase, the Cochrane Library, Chinese biomedicine literature database (CBM), reference lists of reports, and reviews were searched for randomized controlled trials (RCTs), or quasi-RCTs of tamsulosin versus terazosin in BPH. Twelve studies inv...
متن کاملA Randomized, Open-Label, Comparative Study of Efficacy and Safety of Tolterodine Combined with Tamsulosin or Doxazosin in Patients with Benign Prostatic Hyperplasia
BACKGROUND Benign prostatic hyperplasia (BPH), a common disease in men over age 50 years, often causes bladder outlet obstruction and lower urinary tract symptoms (LUTS). Alpha blockers in combination with muscarinic receptor antagonists may have the potential to improve symptoms. This study aimed to assess the efficacy and safety of doxazosin or tamsulosin combined with tolterodine extend rele...
متن کاملBenign Prostatic Hyperplasia: from Bench to Clinic
Benign prostatic hyperplasia (BPH) is a prevalent disease, especially in old men, and often results in lower urinary tract symptoms (LUTS). This chronic disease has important care implications and financial risks to the health care system. LUTS are caused not only by mechanical prostatic obstruction but also by the dynamic component of obstruction. The exact etiology of BPH and its consequences...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2005